Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Arcellx Announces Executive Appointments
Arcellx, Inc.April 19, 2021 GMT
GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new executives to join the company’s leadership team. Dr. Christopher Heery has been named Chief Medical Officer (CMO) where he will have responsibility for clinical, regulatory and medical affairs and Neeraj Teotia has been named Chief Commercial Officer where he will have responsibility for marketing, sales, and health economics and reimbursement.
“We are excited to strengthen our leadership team with the additions of Chris and Neeraj as they bring significant expertise to Arcellx and reflect our values and culture. They will lead two critically important areas advancing our clinical programs to meet all requirements for regulatory approvals and ensu
Published: Apr 19, 2021
GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) -Arcellx Inc. a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new executives to join the company’s leadership team. Dr. Christopher Heery has been named Chief Medical Officer (CMO) where he will have responsibility for clinical, regulatory and medical affairs and Neeraj Teotia has been named Chief Commercial Officer where he will have responsibility for marketing, sales, and health economics and reimbursement.
“We are excited to strengthen our leadership team with the additions of Chris and Neeraj as they bring significant expertise to Arcellx and reflect our values and culture. They will lead two critically important areas advancing our clinical programs to meet all requirements for regulatory approvals and ensuring successful commercialization post approval,” said Rami Elghandour, Chairman and Chief Executive Officer of Arcellx. “Chris will le
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board
February 16, 2021 GMT
ELK CITY, Idaho, Feb. 16, 2021 /PRNewswire/ Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today appointment of Dr. Boris Minev to the Scientific Advisory Board of the Company. Dr. Minev joins other internationally renowned tumor immunologists including Dr. Francesco Marincola, Dr. Santosh Kesari, and Dr. Feng Lin.
Dr. Boris Minev is currently the President of Medical and Scientific Affairs at Calidi Biotherapeutics, Inc. in San Diego, CA. Dr. Minev has a stellar track record of successes in the area of cancer immunotherapy, being a developer of Melacine® the first tumor vaccine to obtain regulatory approval. He held a position as the Director of Immunotherapy and Translational Oncology at Genelux Corpo